Roche Vows To Appeal $12.9M Accutane Verdict

By Ben James

Law360, New York (November 20, 2008, 12:00 AM ET) -- Hoffmann-La Roche has vowed to appeal after three plaintiffs who claimed they developed inflammatory bowel disease after taking the acne drug Accutane were awarded almost $13 million by a New Jersey jury Wednesday afternoon.

The verdict followed a five-week trial in New Jersey Superior Court in Atlantic City. There were three separate cases, but they were tried as one. The defendants were Hoffmann-La Roche and Roche Laboratories Inc.

With respect to each individual plaintiff, the jury voted 7-1 that Roche failed to provide an adequate warning...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles